Shkreli insults Congress on Twitter when refusing to testify

Former Turing prescription drugs Chief military officer Martin Shkreli on Thursday known as members of the U.S. Congress "imbeciles" on Twitter, moments when he refused to testify before a House of Representatives committee on why his company raised the worth of a saving medication five,000 %.

"Hard to simply accept that these imbeciles represent the individuals in our government," aforementioned Shkreli, mistreatment his @MartinShkreli Twitter handle.

He added, "I had previous counsel turn out a memorandum on facial expressions throughout legislative assembly testimony if anyone desires to ascertain it. fascinating precedence."

Earlier, Shkreli invoked his Fifth Amendment right against incrimination and declined to answer queries from lawmakers concerning drug value will increase he designed like hiking the worth of 62-year-old Daraprim to $750 a pill from $13.50.

During the hearing, Shkreli, whose youth and perspective have prompted some critics to label him "Pharmabro," tried and true queries by continued to laugh, twirling a pencil and yawning.

After his look, he conjointly retweeted many posts from supporters, as well as one from Michael J Lis (‏@mikeylis) that said: "Congress ought to simply raise @MartinShkreli queries on Twitter rather than putt them ahead of the house committee."

Shkreli, 32, sparked outrage last year among patients, medical societies and Democratic presidential competition mountain climber Clinton when the massive hike within the value of 62-year-old Daraprim.

Shkreli was a trending topic on social media following the hearing. There square measure concerning thirty posts per minute concerning him on Twitter as of Thursday morning, in keeping with analytics firm Zoomph. About 92,000 individuals were talking concerning Shkreli on Facebook.

His look prompted outrage on Thursday from members of Congress. Bernie Sanders (@BernieSanders), U.S. legislator from Vermont and Democratic presidential candidate, tweeted, "The yank individuals square measure bored stiff with the blatant profiteering of drug company CEOs like Martin Shkreli. It should finish."

U.S. House Representative from American state Michelle Lujan Grisham (@RepLujanGrisham), a Democrat, said: "With all of the smirking, will @MartinShkreli extremely take this issue seriously? #PharmaBro."